Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1CNS 1

Conditions

Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Leukemia, Lymphocytic, Chronic, B-Cell 215Lymphoma, Non-Hodgkin 204Lymphoma, Follicular 193Lymphoma, Large B-Cell, Diffuse 180Leukemia 164Hodgkin Disease 160Multiple Myeloma 118Neoplasms 97Leukemia, Myeloid, Acute 87Lymphoma, Mantle-Cell 78Burkitt Lymphoma 67Myelodysplastic Syndromes 64Lymphoma, B-Cell, Marginal Zone 64Lymphoma, T-Cell, Cutaneous 62Breast Neoplasms 62Mycosis Fungoides 55Recurrence 52Lymphoma, B-Cell 50Hematologic Neoplasms 50Sezary Syndrome 43Waldenstrom Macroglobulinemia 41Myeloproliferative Disorders 39Neoplasms, Plasma Cell 38Lung Neoplasms 34Lymphoma, Large-Cell, Immunoblastic 33Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 32Lymphoma, T-Cell, Peripheral 29Leukemia, Hairy Cell 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Developmental Disabilities × Lymphoid × Clear all
NCT07092852 2025-07-30

PGx Medication Safety Reviews of Persons With IDD

GalenusRx, Inc.

Not yet recruiting
700 enrolled
Lymphoid

Developmental Disabilities, Lymphoma, Follicular, Intellectual Disability

Data powered by HemOnc (CC BY 4.0) Colophon âš¡